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From June to October 2019, 17 patients (six infected, 
11 colonised) with an extensively drug-resistant 
(XDR) Klebsiella pneumoniae strain were notified from 
four Western Pomerania medical facilities. The XDR K. 
pneumoniae  produced carbapenemases NDM-1 and 
OXA-48, and was only susceptible to chlorampheni-
col, tigecycline and cefiderocol. Synergistic activity 
was observed for the combination of aztreonam plus 
ceftazidime-avibactam. Genomic analyses showed all 
isolates belonged to  K. pneumoniae  sequence type 
307. Control measures and further investigations are 
ongoing.
Between June and October 2019, a university hospital, 
two other hospitals and a rehabilitation clinic in north-
eastern Germany (Western Pomerania, Greifswald) 
were affected by an outbreak of extensively drug-resist-
ant (XDR) Klebsiella pneumoniae. A total of 17 patients 
were infected or colonised. The aim of this short article 
is to provide detailed information on the epidemiologi-
cal and microbiological results of this outbreak inves-
tigation, and thereby facilitate comparison with similar 
outbreaks of this emerging Klebsiella strain on interna-
tional level.
Outbreak detection and investigation
Following a routine microbiological screening of tra-
cheal secretion on an intensive care unit (ICU) at a 
university hospital, the first patient with XDR K. pneu-
moniae was detected on 25 June in calendar week 26. 
The patient was placed in a single room and enhanced 
barrier precautions were put in place. Contact patients 
were screened and an admission and exit screen-
ing for colonisation with Gram-negative bacteria 
was performed on the affected ICU in the university 
hospital. Despite extended precautions, further cases 
were detected on six wards at the university hospital 
throughout the following weeks. Under the impression 
of an ongoing outbreak, intensified measures such 
as screening, environmental testing and cohorting of 
cases to a special isolation unit were implemented. In 
the meantime, patients with XDR  K. pneumoniae  were 
detected in a primary-hospital, secondary-hospital and 
rehabilitation clinic in the region.
All isolates from all affected medical facilities were 
sent to the National Reference Centre (NRC) for multid-
rug-resistant (MDR) Gram-negative bacteria in Bochum. 
There the microbiological and molecular analyses of 
corresponding isolates revealed the production of two 
carbapenemases, NDM-1 and OXA-48, and colistin 
resistance.
A case was defined as a person carrying the K. pneumo-
niae outbreak clone as confirmed by molecular typing 
AND having an epidemiological link to the outbreak.
Cases and outbreak information were reported to the 
responsible health authorities. Extensive drug resist-
ance, a high proportion of infections as well as chal-
lenges in outbreak control led to involvement of the 
national public health services (in calendar week 38).
Of the 17 cases (Figure 1), two were female and 15 
were male, with a median age 70 years (range: 50–84 
years). Six cases presented clinical symptoms (sepsis, 
pneumonia, urinary tract infection), 11 cases were colo-
nised; most had severe underlying diseases. Of the 17 
cases, 10 were diagnosed in the university hospital, 
four in a primary hospital, two in the rehabilitation 
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clinic and one in a secondary hospital (Figure 2). All but 
one case had been exposed to treatment in the univer-
sity hospital before the first detection of the outbreak 
clone. The only case not exposed at the university hos-
pital shared the same room with another case in the 
rehabilitation clinic (Figure 2). By 15 October 2019, six 
cases had died apparently from underlying diseases; 
nonetheless, causal links with the outbreak clone are 
under further investigation. 
Microbiological and molecular analyses
Initial antibiotic susceptibility testing (AST) of 10 iso-
lates using semi-automated VITEK 2 (Biomerieux, 
Nürtingen, Germany) analysis and 96-well plate broth 
microdilution (Merlin, Bornheim-Hersel, Germany) 
revealed resistance to a wide range of antibiotics. 
Testing for common carbapenemase gene families indi-
cated presence of bla OXA-48-like and bla NDM in the isolates. 
Furthermore, isolates showed resistance against aztre-
onam and ceftazidime-avibactam. However, to assess 
therapeutic options an Etest synergy assay (bioMé-
rieux, Nürtingen, Germany) with ceftazidime-avibac-
tam and aztreonam was used, with results suggesting 
a synergistic activity. An extended AST showed exten-
sive drug-resistance with susceptibility only to chlo-
ramphenicol, tigecycline and cefiderocol, the latter of 
which is not yet approved for use in European Union/
European Economic Area (EU/EEA) countries.
For early discrimination of outbreak and non-out-
break isolates, a loop-mediated isothermal ampli-
fication (LAMP) assay (eazyplex SuperBug CRE, 
AmplexDiagnostics, Gars, Germany) for rapid detection 
of the carbapenemase genes was included in the uni-
versity hospital laboratory diagnostic procedure.
The NRC performed molecular typing by  XbaI-
macrorestriction analyses in PFGE. Following the cri-
teria of Tenover et al. [1], analyses revealed that all 
isolates of the 17 cases belonged to the same outbreak 
strain (Supplementary Figure S1).
Thirteen isolates from the first eleven patients were 
available for whole-genome sequencing (WGS) 
using the MiSeq System (Illumina, San Diego, United 
States). Sequence analyses and typing were done 
using Kleborate tool and other established methods 
[2-6]. Core genome (cg)MLST analyses with the Ridom 
SeqSphere+  software version 6.0.0 confirmed PFGE 
results, showing a maximum of 12 allelic differences 
between isolates (Figure 3). In silico typing revealed 
that all isolates belonged to sequence type (ST)307 
and cgMLST complex type CT3459, with the capsule 
type K2 (wzi-173,  wzc-939). Sequence analyses apart 
from carbapenemase encoding genes revealed a broad 
spectrum of further resistance genes, e.g.  bla  CTX-M-
15, qnrS1 (Table). There was no evidence for the presence 
of the transmissible colistin resistance gene  mcr-1  or 
related variants. However, amino acid substitutions 
were identified in intrinsic two component systems, 
PmrA/PmrB and PhoP/PhoQ, which have previously 
been shown to mediate colistin resistance [7].
Outbreak control measures
Healthcare facilities, general practitioners and regional 
medical laboratories of the region were informed 
about the outbreak by public health authorities and 
the regional multidrug-resistant organisms (MDRO)-
network on 24.09.2019.
In calendar week 38, an extended outbreak meet-
ing with the federal, state and regional public health 
authorities, the affected facilities and the regional 
MDRO-network was organised to harmonise case 
search, follow-up of cases and hygiene measures. From 
calendar week 39 onwards, all institutions with more 
than one case performed one-time screening of all 
patients, prevalence screening, on all wards to make 
sure that existence of undetected cases was unlikely. 
In addition, a weekly screening was performed for 
6 weeks starting at calendar week 40 on all wards 
where a case had stayed overnight. A notification of 
discharged patients that were hospitalised during the 
outbreak when transmission was not yet controlled, 
was discussed, but not introduced. Instead, all hospi-
tals in the region were asked to perform an admission 
screening on patients that were exposed to one of the 
outbreak facilities from June 2019 onwards. The last 
transmission was detected in calendar week 39.
An overview about this outbreak with a brief description 
of the pathogen was published in the weekly German 
national bulletin on 2 October 2019, and information 
was internationally shared via the European Centre 
for Disease Prevention and Control’s (ECDC) Early 
Warning and Response System (EWRS) and Epidemic 
Intelligence Information System (EPIS) and the World 
Health Organization’s (WHO) Global Antimicrobial 
Resistance Surveillance System-Emerging Antimicrobial 
Resistance Reporting (GLASS-EAR) [9].
Discussion
This is the first reported nosocomial outbreak of 
XDR  K. pneumoniae  ST307 with NDM-1, OXA-48 and 
CTX-M-15 in Germany. Despite established hygiene 
precautions, a university hospital, two other hospitals 
Figure 1
Number of Klebsiella pneumoniae ST307 outbreak cases 
according to date of first detection per calendar week, 
north-eastern Germany, June–October 2019
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and a rehabilitation clinic in north-eastern Germany 
were affected. This may suggest that the outbreak 
clone is highly adapted to the hospital environment. 
Microbiological analyses of the outbreak strain are 
ongoing, preliminary results of susceptibility testing to 
disinfectants does not suggest increased disinfectant 
resistance.
The outbreak seemed controlled until week 44 as no 
new transmissions occurred. In calendar week 44, 
however, Case 18 was detected through admission 
screening in the university hospital. This case had 
been hospitalised during July and September on wards 
of the university hospital with other cases and had 
not been screened during these stays. Identification 
of this case indicates that further unknown cases may 
exist. This highlights the need for close information 
exchange between referral hospitals and for screening 
of patients that were exposed to one of the outbreak 
facilities from June 2019 onwards. A new case was also 
detected through rectal screening in week 45. This 
case, Case 19, stayed on the ward where current cases 
are being cohorted and a recent transmission event 
seems most likely. Again an extended outbreak meet-
ing with all stakeholders was organised in week 46 and 
barrier precautions were reinforced. Currently data col-
lection of these two recent cases as well as sequenc-
ing of the isolates are being conducted. PFGE analysis 
of the new isolates shows that these belonged to the 
outbreak strain. As of calendar week 49, there have 
been no further cases detected.
The mode of transmission is still under investigation, 
but person-to-person transmission is most likely the 
relevant route. In this context, the following two steps 
are especially valuable: ensuring intensified isola-
tion for cases and intensified case searching through 
systematic extended screening immediately when an 
outbreak is suspected, to avoid further unrecognised 
cases. Other outbreaks with similar pathogens have 
shown that systematic rectal screening is crucial to 
identifying colonised patients [10]. Early in-depth anal-
ysis of the molecular and phenotypic strain features 
supports decision making processes for treatment and 
outbreak control.
The first case (index patient) presented no typical risk 
factors for  K. pneumoniae  infection such as a recent 
hospital stay or recent travel, and is therefore unlikely 
to be the primary case that brought the outbreak 
strain into the university hospital. As exemplified by 
the detection of Case 18, there may have been unde-
tected cases, especially during the early phase of the 
outbreak. All but one case (of the 19 cases) had a his-
tory of hospitalisation in the university hospital, which 
is the only tertiary hospital in the affected region. 
Transmissions within the other institutions involved 
cannot be ruled out. Cooperation between institutions 
and public health authorities should be intensified, e.g. 
Figure 2
Timeline of Klebsiella pneumoniae ST307 outbreak, north-eastern Germany, June–October 2019
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Time intervals of 10 days between vertical lines. Dates of detection reported as known by the Robert Koch Institute. Case 1 was hospitalised 
on 7 June 2019 and died on 15 October 2019. A total of six cases died, of which Case 4 died after discharge (adate not specified). The first 
detection of the outbreak strain was on 25 June 2019 (Case 1) and Case 17 was detected on 26 September 2019.
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by fostering close, local collaboration between health 
facilities, health departments, laboratories and fur-
ther stakeholders in MDRO-networks. This has already 
been proven to be successful for controlling outbreaks 
with other XDR pathogens [11].
The emergence of XDR  K. pneumoniae  dramatically 
limits treatment options. Only a few outbreaks of  K. 
pneumoniae  with the carbapenemase combination 
of NDM-1 and OXA-48 have been described [12,13]. 
Furthermore, presence of both carbapenemases 
NDM-1 and OXA-48 were identified in other K. pneumo-
niae  sequence types [14,15], but rarely in ST307 [16]. 
However, CTX-M-15-associated  K. pneumoniae  ST307 
with OXA-48 and colistin resistance was reported in a 
Serbian hospital in 2015 [7]. Wyres et al. [17] recently 
described CTX-M-15-associated  K. pneumoniae  ST307 
as a highly successful, globally emerging lineage with 
remarkable level of plasmid conservation.
Clinical and laboratory staff need to increase vigilance 
in order to improve early detection of XDR outbreaks. 
Early extensive screening and a high level of isola-
tion precautions are needed to avoid further spread of 
these pathogens. As consequence of this outbreak, the 
detection of an XDR enterobacterial strain in an area 
with low endemicity emphasizes the need for increased 
awareness and risk mitigation measures to avoid trans-
mission events.
Figure 3
Minimum spanning tree of 13 XDR Klebsiella pneumoniae ST307/CT3459 isolates of the outbreak based on allelic profiles, 
north-eastern Germany, June–October 2019
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For each isolate, an allelic profile was determined by cgMLST analysis using the Ridom SeqSphere+  software version 6.0.0. These profiles 
were used to determine both the complex type CT3459 and the genetic distances between isolates. Results visualise relatedness of isolates 
on core-genome scale as minimum spanning tree (MST). The MST was calculated with the option ‘pairwise ignore missing values’. Each 
resulting circle represents a distinct allelic profile. Cases from which the isolates were collected are shown for each allelic profile. Two 
isolates from Case 4 showed identical allelic profiles and were grouped together in a single circle (see also Case 7 and Case 8). Numbers on 
connecting lines represent allele differences between allelic profiles. Colours of circles indicate for each case the hospital where the outbreak 
strain was detected for the first time.
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